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Background: We assessed patient outcomes 90 days after hospital admission for stroke 
following a multidisciplinary intervention targeting evidence-based management of fever, 
hyper glycaemia, and swallowing dysfunction in acute stroke units (ASUs). 
Methods: In the Quality in Acute Stroke Care (QASC) study, a single-blind cluster 
randomised controlled trial, we randomised ASUs (clusters) in New South Wales, Australia, 
with immediate access to CT and on-site high dependency units, to intervention or control 
group. Patients were eligible if they spoke English, were aged 18 years or older, had had an 
ischaemic stroke or intracerebral haemorrhage, and presented within 48 h of onset of 
symptoms.  
Intervention: ASUs received treatment protocols to manage fever, hyperglycaemia, and 
swallowing dysfunction with multidisciplinary team building workshops to address 
implementation barriers. Control ASUs received only an abridged version of existing 
guidelines. We recruited pre-intervention and post-intervention patient cohorts to compare 
90-day death or dependency (modifi ed Rankin scale [mRS] ≥2), functional dependency 
(Barthel index), and SF-36 physical and mental component summary scores. Research 
assistants, the statistician, and patients were masked to trial groups. All analyses were done 
by intention to treat. This trial is registered at the Australia New Zealand Clinical Trial 
Registry (ANZCTR), number ACTRN12608000563369. 
Findings: 19 ASUs were randomly assigned to intervention (n=10) or control (n=9). Of 6564 
assessed for eligibility, 1696 patients’ data were obtained (687 pre-intervention; 1009 post-
intervention). Results showed that, irrespective of stroke severity, intervention ASU patients 
were significantly less likely to be dead or dependent (mRS ≥2) at 90 days than control ASU 
patients (236 [42%] of 558 patients in the intervention group vs 259 [58%] of 449 in the 
control group, p=0.002; number needed to treat 6.4; adjusted absolute difference 15.7% [95% 
CI 5.8–25.4]). They also had a better SF-36 mean physical component summary score (45.6 
[SD 10.2] in the intervention group vs 42.5 [10.5] in the control group, p=0.002; adjusted 
absolute difference 3.4 [95% CI 1.2–5.5]) but no improvement was recorded in mortality (21 
[4%] of 558 in intervention group and 24 [5%] of 451 in the control group, p=0.36), SF-36 
mean mental component summary score (49.5 [10.9] in the intervention group vs 49.4 [10.6] 
in the control group, p=0.69) or functional dependency (Barthel Index ≥60: 487 [92%] of 532 
patients vs 380 [90%] of 423 patients; p=0.44). 
Interpretation: Implementation of multidisciplinary supported evidence-based protocols 
initiated by nurses for the management of fever, hyperglycaemia, and swallowing, 
dysfunction delivers better patient outcomes after discharge from stroke units. Our findings 
show the possibility to augment stroke unit care. 
Funding: National Health & Medical Research Council ID 353803, St Vincent’s Clinic 
Foundation, the Curran Foundation, Australian Diabetes Society-Servier, the College of 
Nursing, and Australian Catholic University.
INTRODUCTION 
Although organised stroke unit care significantly reduces death and disability from 
cerebrovascular,1 three physiological variables are not yet universally well-managed despite 
their importance for long-term patient recovery.2-4In the first days of an acute stroke, 
temperature above 37·5ºC occurs in 20-50% of patients;2 up to 50% of patients become 
hyperglycaemic;3 and 37-78%4 experience dysphagia; all result in increased morbidity and 
mortality.2-4 Hence, international guidelines recommend that fever and elevated blood glucose 
levels be monitored and managed proactively and that every stroke patient has their 
swallowing status evaluated before receiving food, fluid or oral medication.5, 6 All these 
recommendations are the responsibility of the stroke multidisciplinary team.7 Care is not 
always consistent with these recommendations however.6, 8 We designed the Quality in Acute 
Stroke Care (QASC) study, a cluster randomised controlled trial (CRCT), 9, 10 to evaluate the 
effect on 90-day post-stroke patient outcomes of multidisciplinary team building workshops 
and a standardised interactive education program to implement evidence-based treatment 
protocols for the management of fever, hyperglycaemia and swallowing dysfunction.  These 
three parameters were selected because they involve multidisciplinary teamwork, which has 
been demonstrated to improve healthcare processes and patient outcomes,11 a priority for 
stroke care.  
 
METHOD 
Our single blind CRCT design randomised Acute Stroke Units (ASUs) to minimise 
contamination because our team building intervention was designed for implementation at the 
ASU level.12  Pre-and post-intervention outcomes were assessed at the patient level.  The trial 
protocol previously has been published.9  
 
Participants 
ASUs eligible to participate were those located in large, tertiary referral centres in New South 
Wales (NSW), Australia who provided care for stroke patients in a geographically defined 
location with immediate CT access and on-site high dependency units (Australian National 
Stroke Unit Program Category A or B) (n=20).  Category A ASUs have access to on-site 
neurosurgery while Category B do not.13Patients were eligible if they: spoke English, were 
aged over 18 years, had a diagnosis of ischaemic stroke or intracerebral haemorrhage and 
presented within 48 hours of onset of symptoms to a participating ASU. Patients were 
excluded if they did not have a telephone or were admitted for palliative care.  
 
Pre-intervention patient cohort 
Prior to randomisation, a pre-intervention patient cohort was recruited (August 2005 to 
October 2007) to provide a baseline sample prior to implementation of the intervention. 
Patients consented to medical record access and to participation in a telephone survey 90-
days following hospital admission.  
 
Post-intervention patient cohort 
Using identical procedures and instruments, a second post-intervention patient cohort was 




All outcome measures pertained to the level of the individual (patient) and all used tools 
previously validated for telephone administration.14-16   
Primary outcomes: 90 days post-hospital admission 
1. death or dependency (dependency: modified Rankin Scale (mRS) ≥ 2)17 
2. functional dependency [Barthel Index (BI)]18 
3. mean SF-36 mental component summary (MCS) score19 
4. mean physical component summary (PCS) score19 
We also undertook subgroup analyses by stroke severity. 
Secondary outcomes: Processes of care 
1. mean temperature for the first 72 hours following ASU admission 
2. mean finger-prick blood glucose level for the first 72 hours following ASU admission 
3. proportion with swallowing screening undertaken within the first 24 hours of ASU 
admission 
4. discharge diagnosis of aspiration pneumonia (ICD 10) 
5. length of hospital stay 
 
Data Collection 
90-day patient outcome instrument 
An independent organisation was contracted to conduct Computer Assisted Telephone 
Interviews (CATIs) with patients 90-days following hospital admission. The two interviewers 
underwent on-line training and competency assessment for mRS administration. 
 
Processes of Care 
Blinded retrospective medical record audits were undertaken using data documented 
prospectively. Four auditors collected: age; sex; stroke sub-type (Oxfordshire Community 
Stroke Project classification);20 time from onset of symptoms to ASU presentation; stroke 
severity (Los Angeles Motor Scale (LAMS)),21 administration of thrombolysis; all 
temperature and blood glucose levels within the first 72 hours of admission to an ASU; 
swallowing screening performed within the first 24 hours of ASU admission; and discharge 
diagnosis of aspiration pneumonia. Auditors attended a 2-day training program. Two auditors 
abstracted data from 95% of medical records, enabling clarification of uncertainties. For 
quality assurance purposes, for the first 700 audits, 10% were re-audited with agreement 
occurring 95% of the time. 
 
Randomisation 
ASUs were stratified (Category A or B) and then by absolute numbers of pre-intervention 
cohort patients recruited. ‘High’ recruiters had consented more than two patients per month; 
‘low’ recruiters two or fewer per month. De-identified stratification details were provided to 
an independent statistician who used random number generating software to randomise 
within strata with allocation concealed until provided to the Project Officer who assigned 
ASUs to their groups. Clinical Research Assistants blind to trial design enrolled patients. 
Patients were blind to ASU group allocation but not clinicians delivering our intervention. 
Research assistants who undertook the CATIs and the medical record audits were blind to 
trial aims, design and group allocation; the trial statistician was blind to group allocation. 
 
Intervention 
Our Fever, Sugar, Swallowing (FeSS) intervention targeted all ASU clinicians, focusing on 
barrier identification,22 reinforcement of multidisciplinary teamwork,23 local adaptation24 and 
use of site champions.25 Using recommendations from Australia’s national clinical guidelines 
for stroke,6 panels of experts developed clinical treatment protocols for management of fever, 
hyperglycaemia and swallowing for the first 72 hours following ASU admission (Box 1). We 
aimed to trigger prompt nursing assessment and bedside treatment. Specifically, two 
teambuilding workshops were conducted to identify local barriers to multidisciplinary care22 
and enablers to implementation of the nurse-initiated treatment protocols. Two additional 
site-based interactive and didactic educational outreach meetings, 26, 27 then were conducted 
for clinicians to discuss the protocols. On-going activities comprised reminders,28 site visits, 
telephone and email support (Box 1).  Protocols and further information about 
implementation of the intervention are available at www.acu.edu.au/qasc. 
 
Control group ASUs received only an abridged version of existing guidelines.29 
 
The intervention ran from May 2007 to August 2010. Following implementation, we allowed 
a three month ‘bedding down’ period prior to recruitment of the post-intervention cohort. 
 
Data Analysis 
Intention-to-treat analyses were undertaken using SAS v9·2 software. The Barthel Index is 
usually reported as a dichotomized variable but the cut points vary; we report both BI > 60 
and BI > 95, the two most conventionally reported cut points in order to allow for comparison 
with published data.18 Continuous and categorical data were summarised using conventional 
descriptive statistics. All outcomes including the sub-group analyses were adjusted for pre-
intervention levels and for clustering within ASUs, using a logistic regression model fitted 
within a generalised estimating equation framework for dichotomous outcomes and a random 
intercept linear regression model for continuous outcomes. The linear and logistic models 
included the predictor variables of period (before and after), intervention and the interaction 
between period and intervention. The P-value from the Wald test for the interaction term was 
used to determine if the pre-post change in the intervention group was statistically different to 
the change in the control group. The confidence intervals reported are those for the 
interaction term from the logistic or linear model but to obtain estimates of absolute 
difference, the models for dichotomous outcomes were refit using an identity link function. 
P-values for the interaction term from these models were almost identical to the logistic 
models.. In order to control the type 1 error rate from the four primary outcome measures, our 
Alpha level was set at 0·0125. 
 
We calculated each patient's mean temperature and blood glucose levels for the first 72 hours 
of their admission to the ASU and, using these, then determined a mean intervention and 
control ASU temperature and glucose level. Three elements were required to meet the criteria 
for swallowing screening, namely, assessment of level of consciousness; cranial nerve 
assessment; and water swallow test. 
 
Sample Size 
There were 19 clusters with a mean cluster size of 39 consenting patients in the pre-
intervention cohort (median 31; minimum 10, maximum 83). In the post-intervention cohort 
the mean cluster size was 59 consenting patients (median 58; minimum: 13, maximum 145). 
We achieved our desired sample size consistent with our earlier statistical assumptions.9 
 
This trial was approved by the Human Research Ethics Committee of  Australian Catholic 
University and the relevant ethics committees of all  participating hospitals. The trial was 
governed by a Steering Committee comprising all investigators and an Expert Advisory 
Committee comprising independent researchers and stroke clinicians.  
 
RESULTS 
Nineteen (95%) ASUs agreed to participate. Figure 1 represents cluster and participants’ flow 
over the course of the trial. 
 
Pre-Intervention Data 
Data for the pre-intervention patient cohort have been published.10 Age, sex, 90-day death, 
90-day death and dependency, 90-day functional dependency (BI) and health status (PCS 
score and MCS score) were similar for the intervention and control groups. 
 
Post-Intervention Cohort 
Of the 1292 eligible patients, 166 (13%) declined to participate [intervention: n=81 (11%); 
control: n=85 (15%)], resulting in 1126 (87%) consenting patients. Patients who agreed to 
participate were similar to those who did not consent in terms of age (P=0·14) and sex 
(P=0·19). There were no significant differences between consenting patients who provided 
full 90-day data and those who subsequently declined; 10% of patients were lost to follow-up 
or withdrew (n=117) [intervention: n=68 (11%); control: n=49 (9·8%)]. There was no 
difference between the number of patients who provided 90-day data and the number of 
relatives who provided 90-day proxy data [intervention: n=433 (81%); control: n=325 (76%), 
P=0·236]. Age, sex, pre-morbid level of dependency (mRS), stroke location, stroke severity, 
and time between onset of stroke symptoms and arrival at ASU were similar for patients in 
the intervention and control groups although fulltime employment appeared slightly lower in 
the control group. (Table 1). Only 7% (n=77) received thrombolysis and the majority of these 
were in the control group (n=60, 78%).  
 
90-day Outcomes 
After adjusting for baseline levels, patients from intervention ASUs were significantly less 
likely to be dead or dependent at 90-days (mRS > 2) than patients from control ASUs (n=236 
42% vs n=259, 58%, P=0·002) (Figure 2) (number needed to treat (NNT) approximately 6·4; 
adjusted absolute difference: 15·7% (95% CI: 5·8 to 25·4). There was no significant 
difference in 90-day mortality between patients from intervention and control ASUs (n=21, 
3·8% vs n=24, 5·3%, P=0·36) nor for functional dependency where BI > 60 (intervention 
n=487, 92% vs control n=380 90%, P=0·44) or BI > 95 (intervention n=367 69% vs control 
n=254 60%, P=0·07) (Table 2). 
Patients from intervention ASUs were significantly more likely to have better SF-36 physical 
health scores indicating improved physical functioning (mean PCS score 45·6 vs 42·5, 
P=0·002) (adjusted absolute difference 3·4 (95% CI: 1·2 to 5·5)) but there were no 
significant differences for mental health (mean MCS score 49·5 vs 49·4, P=0·69) (Table 2).  
 
Our exploratory sub-group analyses by stroke severity demonstrated that patients with a mild 
stroke (LAMS = 0) from intervention ASUs were significantly less likely to be dead or 
dependent at 90-days (mRS > 2) (n=56) than those from control ASUs (n=71) (25% vs 39%, 
P=0·02) and reported better physical health (PCS score mean 48·3 vs 45·0; p=0·008) than 
those from control ASUs. Similarly, patients with a more severe stroke (LAMS ≥ 1) from 
intervention group ASUs were significantly less likely to be dead or dependent at 90 days 
(mRS > 2) (n=178) than those from control ASUs (n=181) (54% vs 70%, P=0·04) and had 
better physical health (PCS score mean 43·6 vs 40·8; p=0·04) than patients from control 
ASUs. Further, intervention ASU patients with more severe strokes (n=17) were also less 
likely to have died at 90-days than patients from control ASUs (n=23) (5·2% vs 8·8%, 
P≤0·001). 
 
Processes of Care 
 
Medical records were unavailable for 40 patients (3·6%) resulting in collection of processes 
of care data for 1086 patients (intervention: n=603; control: n=483) (Table 3). Patients in 
intervention ASUs had a significantly lower mean temperature during the first 72 hours of 
admission to the ASU (36·5ºC vs 36·6ºC, P=0·001) compared with patients in the control 
ASUs. Post-hoc explanatory analyses demonstrated a statistically significant reduction in the 
number of patients from intervention ASUs who had at least one high (>37·5ºC) temperature 
(n=105, 17% vs n=131, 27%, P<0·001). In addition, patients from intervention ASUs had 
significantly lower mean blood glucose levels during the first 72 hours following ASU 
admission (6·8 mmol/L versus 7·0 mmol/L, P=0·02). Patients in intervention ASUs were 
significantly more likely to receive a swallowing screen within the first 24 hours of ASU 
admission (n=242) compared with patients in the control group (n=24) (46% vs 7%, 
P<0·001) (Table 3). There were no differences between aspiration pneumonia rates between 
groups [n=13, 2·2% vs n=13, 2·7%, P=0·82). The mean (SD) length of hospital stay was 11·3 
(10·3) days for patients from intervention ASUs and 13·7 (12·7) days for patients from 




Our results demonstrate that patients of ASUs allocated to receive our multidisciplinary 
intervention to support proactive evidence-based management of fever, hyperglycaemia and 
swallowing were significantly more likely to be alive and less dependent at 90-days post-
admission. Specifically, we found a 15·7% adjusted absolute difference in rates of 90 day 
death and dependency. The clinical significance of these results is more remarkable when 
compared against other established clinical and organisational interventions, namely 
administration of aspirin within 48 hours,30 stroke unit care1
 
and thrombolysis within 4·5 
hours.31 All deliver absolute benefit for independent survival of no more than 10%; all have 
higher NNT (aspirin NNT:7930; stroke unit NNT: 181; thrombolysis: NNT: 832 to 14 
31depending on onset to treatment time) than our intervention to realise a benefit, with tPA 
available only to a very specific ischaemic stroke population, unlike our intervention which 
has relevance for all stroke patients. Hence, the 15·7% improvement and NNT of 6·4 seen 
with our FeSS intervention will be of immediate importance for clinicians, patients and their 
carers. 
 
Furthermore, our data show that patients from ASUs who received our intervention also had 
significantly improved processes of care. The mean temperature decreased significantly by 
0·1 (from 36·6ºC to 36·5ºC) in intervention ASU patients and, while this small difference 
occurred within the afebrile temperature range, our analyses incorporated all patients 
including those who never had a fever, making this change all the more potentially important. 
That there were fewer patients with a fever in the intervention group also is of interest, 
possibly due to improved observation and early intervention. The mean glucose level also 
significantly decreased in patients receiving care in intervention ASUs (7·02 to 6·81 
mmol/L), demonstrating the positive effect of our intervention on glucose management.  
 
Although the proportion of swallowing screenings attended was significantly higher in 
patients from intervention ASUs when compared with patients from control group ASUs, the 
absolute performance appears low.  We used very conservative screening criteria, however, 
and intentionally did not capture screening occurring outside the ASU, nor swallowing 
assessments that could also have had a screening component occurring within 24 hrs of 
admission.  Although not shown to be significant, the promise of reduced length of stay also 
could represent substantial savings for hospitals. 
 
Despite being implemented with multidisciplinary support from physicians, speech 
pathologists and nurses, our clinical protocols were delivered by bed-side nurses. Protocol-
led care enabled nurses to be proactive in their management of fever, hyperglycaemia and 
swallowing. Role delineation within multidisciplinary teams has clear benefit for patients, 
ensuring that critical physiological parameters are monitored and managed. We are confident 
that future behaviour change interventions could still further raise the quality of care received 
by stroke patients in Australian hospitals.  Replicability of our intervention would enable 
wider implementation in other ASUs with clinical leadership and change management 
provided by stroke networks and non-government organisations such as stroke charities. 
 
On a methodological note, we achieved excellent engagement (19 out of the 20 NSW ASUs), 
also recruiting large cohorts of patients with a modest rate of loss-to-follow-up (10%, n=117).  
Of note, our death and dependency results remained significant (P=0·004) when a sensitivity 
analysis was undertaken where we assumed all patients lost to follow-up were dead or 
disabled (mRS > 2).  Our extension of the data endpoints to encompass both 90-day patient 
outcomes and processes of care is exceptional in stroke research and we encourage similar 
scope in future studies. 
 
Similar to many acute stroke studies,33 our study was limited in that patients with severe 
strokes were under-represented.  This under-representation was probably due to our 
deliberate exclusion of patients with severe stroke who were for palliation only.  Exclusion of 
these patients also may account for the non-significant differences between groups in 
functional dependency and mortality.  However, our sub-group analyses showed significant 
improvements for death and dependency outcomes for both mild and severe strokes in our 
intervention group (14% in the mild stroke cohort and 16% in the more severe stroke cohort) 
showing a clear benefit for both mild and more severe strokes.  
 
Other opportunities to improve patient outcomes have emerged. Prompt recognition of stroke 
in emergency departments and better triage are crucial for those eligible for thrombolysis and 
if new treatments such as the FeSS intervention34 or early rehabilitation35 are to be started, 
then timely admission to an ASU is imperative. As our intervention focussed on care of 
patients admitted to ASUs, our findings are not necessarily generalisable to stroke patients 
cared for in general medical wards. They also are only generalisable to patients admitted to 
ASUs within 48 hours of symptom onset and who receive the protocol-led care for the first 
72 hours following admission to an ASU. Because access to a stroke unit for all stroke 
patients is not always achievable and delays often occur, we recommend future trials to 
examine the effect of similar multidisciplinary interventions in general wards and emergency 
departments. 
 
Our trial provides compelling evidence that better management of fever, hyperglycaemia and 
swallowing in acute stroke patients during the initial 72 hours of admission to an ASU can 
result in decreased rates of death, dependency and improved processes of care. Furthermore, 
ours is one of the few to clearly show the effect of good nursing care on death and depency. 
Additionally, it is one of the first implementation trials in acute stroke to harness the stroke 
unit network in Australia. To our knowledge, it also is one of the largest multidisciplinary 
rigorously evaluated interventions in acute stroke. The importance of our intervention lies in 
its ability to augment the benefits of stroke unit care. Further research as to its potential to 
benefit stroke patients unable to access immediate stroke unit care and also its value for 
populations other than stroke is warranted. 
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Research in Context 
Systematic review 
In the first days of an acute stroke, temperature above 37.5ºC occurs in 20-50% of patients; 
up to 68% of patients become hyperglycaemic; and 37% to 78% experience dysphagia, 
resulting in increased morbidity and mortality and enlarged infarct size.  We searched 
MEDLINE and CINAHL databases using the search term ‘stroke’ (all inclusive) combined 
with: ‘fever’; ‘pyrexia’; ‘hyperthermia’; ‘hyperglycaemia’; and ‘glucose’ and determined there were  
no systematic reviews of treatments to effectively manage either physiological parameter.  
Similarly, we also combined the term ‘stroke’ with ‘dysphagia’; ‘swallow/ deglutition’; and 
‘swallowing disorders/ deglutition disorders’.  Evidence from a systematic review demonstrated 
that stroke patients with dysphagia are at risk of pneumonia and that this risk is higher in 
patients who aspirate.  Use of a formal dysphagia screen can decrease the risk of pneumonia.  
In addition, no studies have examined the combined effect of systematic management of 
fever, hyperglycaemia or swallowing.  International guidelines recommend monitoring and 
prompt treatment of these three variables.  There is no ‘magic bullet’, however, with which to 
change bedside care and ensure multidisciplinary teams comply with evidence-based clinical 
practice guidelines.  Systematic reviews of strategies with this goal in mind persistently argue 
that more implementation research is needed to identify effective strategies and to ensure 
resources are not wasted on activities of questionable value.  In response, our research tested 
a multidisciplinary intervention designed to raise standards of care in acute stroke units using 
a cluster randomised controlled trial.  Barrier identification, educational meetings, use of 
local opinion leaders and reminders have shown promise in earlier studies in diverse clinical 
settings and we incorporated these elements in our intervention and evaluated long-term 
patient outcomes of 90-day death and dependency.  We also examined processes of care.  
Interpretation 
The QASC trial provides high-quality evidence that a guideline implementation strategy to 
support multidisciplinary team work focussed on evidence-based management of three key 
physiological parameters delivers significantly better post-discharge outcomes for stroke 
patients.  Clinical leaders of stroke services can adopt this strategy with confidence that their 
outcomes will improve.   
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<65 137 (28%) 195 (31%) 
65 to <75 130 (26%) 150 (24%) 
75 to <85 158 (32%) 181 (29%) 
85+ 73 (15%) 99 (16%) 
Gender 
Male 298 (60%) 376 (60%) 




Total Anterior Circulation Infarct 27 (9·1%) 42 (7·2%) 
Partial Anterior Circulation Infarct 121 (41%) 298 (51%) 
Lacunar Infarct 82 (28%) 93 (16%) 
Posterior Circulation Infarct 54 (18%) 113 (19%) 
Intracerebral Haemorrhage 12 (4·1%) 39 (6·7%) 
Los Angeles Motor Scale 
0 (mild stroke) 203 (41%) 262 (42%) 
>1 (more severe stroke) 290 (59%) 360 (58%) 
Aborigine or Torres Strait 
Islander 
Yes 6 (1·4%) 5 (0·9%) 
Marital Status 
Never married 20 (4·7%) 41 (7·7%) 
Married 269 (63%) 323 (60%) 
Widowed/Divorced/Separated 136 (32%) 171 (32%) 
Highest level of education 
No school certificate 145 (34%) 130 (25%) 
School Certificate 177 (42%) 187 (35%) 
Higher School Certificate 43 (10%) 93 (18%) 
University/TAFE/College 59 (14%) 119 (22%) 
Employment status 
Retired 297 (70%) 357 (67%) 
Employed full-time 28 (6·6%) 74 (14%) 
Permanently unable to work or ill 60 (14%) 43 (8·0%) 
Employed part-time or casual 18 (4·2%) 46 (8·6%) 
Unemployed/Home 
duties/Volunteer work/Student 
22 (5·2%) 15 (2·8%) 
Premorbid mRS 
No symptoms at all 376 (88%) 477 (89%) 
No significant disability despite 
symptoms 
18 (4·2%) 18 (3·4%) 
Slight disability 18 (4·2%) 22 (4·1%) 
Moderate disability 11 (2·6%) 18 (3·4%) 
Moderately severe disability 2 (0·5%) 2 (0·4%) 
Time from onset of 
symptoms to ASU (mins) 
Mean (SD) 826 (701) 953 (648) 
† P-values are adjusted for clustering within ASU 
Table 2: Primary Outcomes: Number (%) or mean (SD) 90-day post-hospital admission 






Difference in absolute 
change 
(95% CI) 
Death and dependency (mRS > 2) 
(0·018) 
259 (58%) 236 (42%) 0·002 15·7% (5·8% to 
25·4%) 
Barthel Index 










9·5% (-0·5% to 19·5%) 
BI > 60 
(0·009) 
380 (90%) 487 (92%) 0·44 2·5% (-3·6% to 8·6%) 
SF-36 Physical health (PCS score) 
(0·026) 
42·5 (10·5) 45·6 (10·2) 0·002 3·4 (1·2 to 5·5) 
SF-36 Mental health (MCS score) 
(0·011) 
49·4 (10·6) 49·5 (10·9) 0·69 0·5 (-1·9 to 2·8) 
† P-values are for the interaction term between intervention group and time period (pre or post intervention) and 
adjusted for clustering within ASU 






Table 3: Secondary Outcomes: Processes of care measures for fever, glucose and swallowing screening 
 Group   










Mean temperature during first 72 hours 











(0·04 to 0·15) 
At least one temperature > 37·5ºC in 











(8·3 to 24·6) 
Glucose  
Mean glucose level during first 72 











(0·08 to 1·01) 
Swallowing Screening  
Swallowing screening within 24 hours 















Length of hospital stay (days) Mean (SD)  13·7 (12·7) 11·3 (10·3) 0.144 1·5 (-0·5 to 
3·5) 
† P-values are for the interaction term between intervention group and time period (pre or post intervention) and 
are adjusted for clustering within ASUs 
^ Intra-cluster correlation co-efficient (ICC) 
# excludes those screened in ED 
 
 




* % may not total to 100% due to rounding 
 
 































ASU: Acute stroke unit 
IV: Intravenous 
PR: Per rectum 
DVD: Digital video disc 
 
^ FeSS treatment protocols and ASSIST dysphagia screening tool available on application to authors  
 





1. Clinical treatment protocols for FeSS management by nurses for first 72 hours of ASU care: key 
elements 
 Fever 
1. Temperature monitored & charted 4 hourly for 72 hours following admission to ASU. 
2. Temperature >37·5°C treated with paracetamol (IV, PR or oral), unless clinically contraindicated. 
 Sugar (Hyperglycaemia) 
1. Formal glucose measured (venous blood not finger prick) on admission to hospital or admission to 
the ASU. 
2. 1-6 hourly fingerprick blood glucose levels for 72 hours following admission depending on 
previous blood glucose level. 
3. On admission, if blood glucose level between 8 and 16 commence saline infusion. 
If blood glucose level > 11 and known diabetic, commence insulin. 
If blood glucose level > 16 and not a diabetic, commence insulin. 
4. If blood glucose level > 11 at any time in first 72 hours following admission, commence insulin. 
 Swallowing 
1. Nurses underwent dysphagia screening education program, which consisted of all nurses attending 
an in-service administered by the speech pathologist using a DVD prepared specifically for this 
study. 
2. Nurses underwent a competency assessment before being able to screen patients, consisting of an 
assessment of clinical knowledge tool, a written test and a clinical competency tool which had to 
be completed on three patients and was assessed by a Speech Pathologist. 
3. Patients were screened using the ASSIST tool by either a nurse who passed the competency test or 
a Speech Pathologist within 24 hrs of admission to ASU; this then was clearly documented in the 
patient’s medical record by use of a sticker. 
4. Patients who failed the swallowing screening were referred to a Speech Pathologist for a 
swallowing assessment. 
2. Site-based education and support 
1. Two multidisciplinary teambuidling workshops to identify local barriers and enablers to 
implementation of the FeSS nurse-initiated treatment protocols. 
2. Two site-based educational outreach meetings consisting of a standardised education program 
about the FeSS treatment protocols delivered by the Project Officer (SD); Powerpoint slides then 
left with ASU Nurse Educator to deliver to those staff who did not attend. 
3. Engagement of local stroke unit co-ordinators through support and feedback.  The Project Officer 
visited each intervention ASU every six weeks.  The Project Officer sent three monthly proactive 
emails to each site and also instigated scheduled telephone follow-up every three months. She also 

























1 excluded,  
ASUs withdrew* 
2366 patients assessed for eligibility  
 
687 patients’ 90- day data analysed of 
which 44 died at 90 days  
Mean cluster size: n=36 patients; 
median 30; minimum 6; maximum 82 
19 clusters consented 
735 patients consented  
Mean cluster size; n=39 patients; 
median 31; minimum 10; 
maximum 83 
20 clusters assessed for eligibility: 
NSW category A and B# ASU 
Figure 1: Pre- intervention trial profile 
NSW= New South Wales. ASU= Acute Stroke Unit. # Australian National Stroke Unit Program Category A or 
B = stroke units with immediate CT access and on-site high dependency units; Category B do not have on-site 




472 no stroke 
373 presented ≥48 hrs to 
stroke unit 
199 palliative care 
153 no English 
136 unable to provide 
informed consent 
82 unknown 
12 no telephone 
5 aged ≤ 18 years 
199 refused to participate 
 
 
48 lost to follow-up at 90 days 
36 lost at 90 days 







10 clusters analysed 
558 patients’ 90-day data analysed of which 20 died at 90 
days 
Mean cluster size: n= 56 patients; median 62; minimum 
15; maximum 131 
10 clusters analysed 
558 patients’ 90-day data analysed of which 20 
died at 90 days 
Mean cluster size: n= 56 patients; median 62; 
minimum 15; maximum 131 
 
19 clusters of ASUs randomised 
10 clusters allocated to intervention 
(all clusters and all patients received allocated intervention) 
1982 patients assessed for eligibility 
 
9 clusters allocated to control (all clusters and 
all patients received allocated control protocol) 
2216 patients assessed for eligibility 
 
  
Figure 2: Post- intervention trial profile 
 
626 patients consented  
Mean cluster size: n= 63 patients; median 67; minimum 16; 
maximum 145 
500 patients consented 
Mean cluster size: n= 56 patients;  
Median 56; minimum 13; maximum 112 
13556 excluded 
1275 ineligible 
420 no stroke 
430 presented ≥ 4.8 h to stroke unit 
160 palliative care 
109 no English 
99 unable to provide informed consent  
49 unknown 
6 no telephone 
2 aged ≤ 18 years 
81 refused to participate 
0 clusters lost to follow-up at 90 days  
68 patients lost to follow- up at 90 days 
 59 lost at 90 days 
 9 withdrew consent at 90 days  
1716 excluded 
1631 ineligible 
776 no stroke 
395 presented ≥ 4.8 h to stroke unit 
230 palliative care 
94 no English 
66 unable to provide informed 
consent 
58 unknown 
11 no telephone 
1 aged ≤ 18 years 
85 refused to participate 
 
  
0 clusters lost to follow-up at 90 days  
49 patients lost to follow- up at 90 days 
 37 lost at 90 days 
 12 withdrew consent at 90 days  
 
